Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: Implications for gene therapy

Gene Therapy

Volumn 4, Issue 3, 1997, Pages 258-263

  Amalfitano, A ^a,b   Chamberlain, J S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

293 cells; Adenovirus; Gene therapy; Packaging; Polymerase; Preterminal protein

Indexed keywords

DNA POLYMERASE; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; CELL LINE; CLONING VECTOR; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIROGENESIS;

EID: 0030892490     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300378     Document Type: Article

References (28)

1. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-72.
2. Imperiale MJ et al. Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity. Mol Cell Biol 1984; 4: 867-874.
3. Nevins JR. Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell 1981; 26: 213-220.
4. Gaynor RB, Berk AJ. Cis-acting induction of adenovirus transcription. Cell 1983; 33: 683-693.
5. Yang Y, Wilson JM. Clearance of adenovirus-infected hepatocytes by MHC class I restricted CD4+ CTLs in vivo. J Immunol 1995; 155: 2564-2570.
6. Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
7. Vincent N et al. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat Genet 1993; 5: 130-134.
8. Yang Y, Xiang Z, Ertl HCJ, Wilson JM. Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc Natl Acad Sci USA 1995; 92: 7257-7261.
9. Amalfitano A, Begy CR, Chamberlain JS. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors. Proc Natl Acad Sci USA 1996; 93: 3352-3356.
10. Zhao LJ, Padmanabhan R. Nuclear transport of adenovirus DNA polymerase is facilitated by interaction with preterminal protein. Cell 1988; 55: 1005-1015.
11. Freimuth PI, Ginsberg HS. Codon insertion mutants of the adenovirus terminal protein. Proc Natl Acad Sci USA 1986; 83: 7816-7820.
12. Schaack J et al. Adenovirus type 5 precursor terminal protein-expressing 293 and HeLa cell lines. J Virol 1995; 69: 4079-4085.
13. Schaack J, Shenk T. Adenovirus terminal protein mediates efficient and timely activation of viral transcription. Curr Top Microbiol Immunol 1989; 144: 185-190.
14. Schaack J, Ho WY, Freimuth P, Shenk T. Adenovirus terminal protein mediates both nuclear matrix association and efficient transcription of adenovirus DNA. Genes Dev 1990; 4: 1197-1208.
15. Hauser MA, Chamberlain JS. Progress towards gene therapy for Duchenne muscular dystrophy. J Endocrinol 1996; 149: 373-378.
16. Yang Y et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet 1994; 7: 362-369.
17. Wang Q, Jia X-C, Finer MH. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions. Gene Therapy 1995; 2: 775-783.
18. Yeh P et al. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J Virol 1996; 70: 559-565.
19. Caravokyri C, Leppard KN. Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5. J Virol 1995; 69: 6627-6633.
20. Krougliak V, Graham FL. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Hum Gene Ther 1995; 6: 1575-1586.
21. Doerfler W Adenovirus DNA, The Viral Genome and its Expression. Martinus Nijhoff Publishing: Boston, 1986.
22. Pronk R, Stuiver MH, Van der Vliet PC. Adenovirus DNA replication: the function of the covalently bound terminal protein. Chromosoma 1992; 102: S39-S45.
23. Mitani K, Graham FL, Caskey CT, Kochanek S. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc Natl Acad Sci USA 1995; 92: 3854-3858.
24. Kumar-Singh R, Chamberlain JS. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum Mol Genet 1996; 5: 913-921.
25. Thomas GP, Mathews MB. DNA replication and the early to late transition in adenovirus infection. Cell 1980; 22: 523-533.
26. Nevins JR, Wilson MC. Regulation of adenovirus-2 gene expression at the level of transcriptional termination and RNA processing. Nature 1981, 290: 113-118.
27. Ghosh-Choudhury G et al. Human adenovirus cloning vectors based on infectious bacterial plasmids. Gene 1986; 50: 161-171.
28. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.